Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Smurfit WestRock plc Ordinary Shares (SW) Price & Performance

Indivior Pharmaceuticals Inc. Common StockTrade
Smurfit WestRock plc Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Indivior Pharmaceuticals Inc. Common Stock vs Smurfit WestRock plc Ordinary Shares — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.18B), while Smurfit WestRock plc Ordinary Shares trades at $41.19 (market cap $21.74B). The key difference: Smurfit WestRock plc Ordinary Shares is far larger — about 5.2× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Smurfit WestRock plc Ordinary Shares pays a 4.36% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Smurfit WestRock plc Ordinary Shares for 5 Days on average.

INDVSW
Market Cap
$4.18B$21.74B
Volume
1,819,7462,458,317
Sector
HealthConsumer Cyclical
52-Week High
$41.83$51.84
52-Week Low
$24.09$32.79
Typical Hold Time
0 Days5 Days
Enterprise Value
$4.47B$35.23B
Dividend Yield
—4.36%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Smurfit WestRock plc Ordinary Shares

Smurfit Westrock (SW) trades at $41.45, showing modest daily gains of 0.93% but facing technical bearish signals with 17 sell indicators versus 4 buys. The company reported three consecutive quarterly earnings misses amid cost pressures, though revenue remains stable above $31 billion. Recent strategic moves include the $420 million acquisition of CMPC's Chilean containerboard business to strengthen regional footprint and reduce costs.

Despite unanimous analyst buy ratings and a $71.50 price target suggesting 72% upside, SW faces execution risks from freight cost inflation and margin compression. The stock's high P/E ratio of 44.01 contrasts with weak profitability metrics (ROE 2.74%), creating a divergence between valuation and fundamental performance that warrants cautious optimism.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INDV
100% Buy0% Sell
Avg holding period · 0 Days
SW

No sentiment data available yet.

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →

About Smurfit WestRock plc Ordinary Shares

Smurfit WestRock plc is an Ireland-headquartered packaging company that manufactures corrugated containers and consumer packaging from containerboard and paperboard, operating mills, converting plants, and recycling facilities across more than 40 countries.

Read more on SW →